Form 4: Molina Healthcare Director Daniel Cooperman Reports Share Acquisition

Director Daniel Cooperman acquired 56 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's equity incentive plan.

Summary

• On April 1, 2025, Daniel Cooperman, a director of Molina Healthcare, Inc., acquired 56 shares of common stock.
• The acquisition was part of the Issuer's 2019 Equity Incentive Plan, related to Cooperman's service as a director.
• The shares were granted at a price of $327.71 per share, reflecting the closing price of Molina Healthcare's common stock on that day.
• This grant is part of a prorated annual equity award for directors, adjusted because Mr. Cooperman will not seek re-election at the 2025 annual stockholders' meeting.
• Following the transaction, Cooperman directly owns 6,383 shares of Molina Healthcare common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and well-governed company. The sentiment is neutral to slightly positive.

Positives

• The equity incentive plan aligns director interests with shareholder value.
• The prorated grant reflects Cooperman's service and contribution as a director.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies. It reflects standard practices for aligning director interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across the healthcare industry.
• Companies like UnitedHealth Group, Anthem, and Cigna also provide equity-based compensation to their directors.
• The specific amount and vesting schedules can vary based on company size, performance, and board structure.
• The $220,000 annual equity award appears to be within the typical range for directors at similarly sized healthcare companies.

Stakeholder Impact

• Shareholders may view the equity grant as aligning director interests with company performance.
• The transaction has a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Molina Healthcare, Daniel Cooperman, Director, Equity Incentive Plan, Share Acquisition, Form 4, Stock Grant